FORM 3A - Director/Chief Executive Notice - Interests in Shares of Listed Corporation
 
Form Serial Number: DA20220421E00275
1. Date of relevant event: 14/04/2022
(dd/mm/yyyy)
2. Date when director became aware of the relevant event/ interest in the shares (if later):
(dd/mm/yyyy)
3. Stock code: 06606
4. Name of listed corporation: New Horizon Health Limited - B 
5. Class of shares: Ordinary Shares 
6. Number of issued shares in class: 429,739,898
7. Name of director (English) as printed on HKID Card/Passport:
(Surname) Chen
(Other names) Yiyou
10. Name of director (Chinese): 陳一友 
11. Chinese Character Code as printed on HKID Card:
 
24. Details of relevant event:
  Brief description of relevant event Capacity in which shares were/are held Number of shares bought/sold or involved Currency of transaction On Exchange Off Exchange
Before relevant event After relevant event Highest price (per share) Average price (per share) Average consideration (per share) Consideration code
Long position 
11031The number of shares in which you are interested has increased because:
you became the holder of, wrote or issued equity derivatives under which (choose one):
you have a right to take the underlying shares
 
 
2101Beneficial owner
 		 138,300         
 
Short position 
 
 
 		            
 
25. Total shares in listed corporation immediately before the relevant event:
 Total number of sharesPercentage figure (%)
Long position50,745,60611.81
 
26. Total shares in listed corporation immediately after the relevant event:
 Total number of sharesPercentage figure (%)
Long position50,883,90611.84
 
27. Capacity in which interests disclosed in Box 26 are held:
Code describing capacityNumber of shares
2101Beneficial owner
Long position41,042,925
2301Trustee
Long position9,840,981
 
28. Further information in derivative interests in listed corporation :
Derivatives code Exercise period (dd/mm/yyyy) Consideration - if derivatives granted by listed corporation Number of shares
  BeginsEndsCurrencyPrice for grantCurrencyExercise priceCurrencyPrice on assignment 
Long position
4105Unlisted derivatives - Physically settled
14/05/201908/10/2024USD0USD0.422  5,521,070
Long position
4101Listed derivatives - Physically settled
 14/04/2026USD0USD0.000  100,600
Long position
4101Listed derivatives - Physically settled
 14/04/2023USD0USD0.000  37,700
 
29. Further information in relation to interests of children under 18 and/or spouse:
Child/SpouseName of child/spouseNumber of shares
 
 
30. Further information in relation to interests of corporations controlled by Director:
Name of controlled corporationAddress and place of incorporationName of controlling person% controlDirect interest (Y/N)Number of shares
   
 
31. Further information in relation to interests held by Director jointly with another person:
Name of joint shareholderAddressNumber of shares
 
 
32. Further information from a director who is a trustee, or beneficiary of a trust, or a person who has set up a Discretionary Trust:
Names of TrustAddressStatus codeNumber of shares
Yiyou Chen Grantor Retained Annuity TrustAddresses of individuals are not displayed.
5101Trustee of a trust
Long position9,840,981
 
33. Further information from a party to an agreement under Section 317 (Please see Notes for further information required):
Names of other partiesAddressNumber of shares
 
Total number of shares in which a director is interested under sections 317 and 318
 
34. Supplementary information: Chen Yiyou was granted in aggregate 138,300 restricted share units, representing 138,300 ordinary shares of New Horizon Health Limited subject to certain vesting conditions under the pre-IPO share incentive plan adopted and approved on October 10, 2018 and further amended and approved on August 17, 2020.
35. Log/Serial Number of the previous form:
36. Number of concert party document(s) under section 317 attached/uploaded:
Date of filing this Form 3A: 21/04/2022
(dd/mm/yyyy)